CD8A and neoplasm: Regulatory T cells can thereby prevent the anti-tumor immune response by inhibiting the function of both tumor-specific effector cells (natural killer cells and NK T cells) and tumor-unspecific effector cells (CD8+ cytotoxic T lymphocytes and CD4+ T helper cells).